Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling (Q36919811)

From Wikidata
Jump to navigation Jump to search
scientific article published on 07 June 2012
edit
Language Label Description Also known as
English
Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling
scientific article published on 07 June 2012

    Statements

    Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit